FTO (Freedom to Operate) in the Pharmaceutical Industry
ISBN:
978-3-8487-5221-8
Verlag:
Nomos
Land des Verlags:
Deutschland
Erscheinungsdatum:
22.08.2018
Reihe:
Munich Intellectual Property Law Center – MIPLC
Format:
Softcover
Seitenanzahl:
63
Lieferung in 5-10 Werktagen
Versandkostenfrei ab 40 Euro in Österreich
FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed.
The author is Hirotaka Nonaka; an attorney-at-law and patent attorney in Tokyo, Japan, handling particularly IP-related disputes and consulting.
Schlagwörter
